Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

Producer of functional foods and supplements for manufacturing and distribution.

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK

Description

Mycodern Spolka Akcyjna is a producer of functional foods and innovative dietary supplements. The company's product portfolio includes items such as functional gummies and oils. Its business activities encompass contract manufacturing, wholesale, trading, and retail distribution.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-18 14:14
Podpisanie umowy o sprawowanie nadzoru nad przebiegiem postępowania restruktury…
Polish 1.7 KB
2025-12-16 17:01
zal01_FormularzA_1.pdf
Polish 77.8 KB
2025-12-16 17:01
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 467 bytes
2025-12-16 09:18
zal01_FormularzA.pdf
Polish 79.4 KB
2025-12-16 09:18
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 436 bytes
2024-04-08 15:20
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB
2023-12-31 20:02
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 183.3 KB
2023-12-31 20:02
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 181.8 KB
2023-12-31 20:02
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
Polish 637 bytes
2023-12-29 22:27
MCD - dokument ofertowy (seria E)
Polish 444.1 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mycodern Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Entera Bio Ltd. Logo
A clinical-stage company developing oral peptide and protein replacement therapies.
United States of America
ENTX
Entero Therapeutics, Inc. Logo
Clinical-stage biopharma developing oral therapies for gastrointestinal diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Clinical-stage biopharma developing EEV-based therapies for rare diseases.
United States of America
TRDA
Develops small molecule therapeutics for cancer, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices for infections based on a proprietary marine enzyme technology.
Sweden
ENZY
Epitomee Medical Ltd. Logo
Develops ingestible therapeutic devices for chronic diseases.
Israel
EPIT
EQL Pharma AB Logo
Develops and sells niche generic and specialty medicines, primarily in Nordic markets.
Sweden
EQL
Erasca, Inc. Logo
A clinical-stage oncology company developing therapies for RAS/MAPK pathway-driven cancers.
United States of America
ERAS
Ernexa Therapeutics Inc. Logo
Biopharmaceutical company developing cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
ERYTECH Pharma S.A. Logo
Develops red blood cell-based therapies for cancer and orphan diseases.
France
ERYP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.